Two drugmakers announced Friday the resumption of U.S. testing of their COVID-19 vaccine candidates.
Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data. Read More
Johnson & Johnson began its final round of testing for its COVID-19 vaccine Wednesday.
The study is one of the most expansive to occur so far, involving 60,000 volunteers across the United States, Argentina, Brazil, Chile, Peru, Mexico and South Africa, the Associated Press reported. The vaccine is the latest to begin its final testing phase, joining candidates developed by Moderna and Pfizer, and is the only vaccine that would be administered as a single dose. Read More
Johnson & Johnson, the medical device company, agreed to a $20.4 million settlement with two Ohio counties in a federal lawsuit over opioid deaths. There are currently more than 100 lawsuits against pharmaceutical companies in the state seeking damages for their role in causing the opioid crisis. Read More
An Oklahoma judge ruled Monday that Johnson & Johnson must pay $572 million to the state of Oklahoma for the company’s part in fueling the opioid crisis. Read More
by Evie Fordham Five of the seven pharmaceutical companies who sent executives to testify on drug pricing before the Senate Finance Committee Tuesday have the top-25 highest-paid pharma CEOs for companies in the S&P 500. CEOs from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer and Sanofi plus Johnson & Johnson’s… Read More